Dan Vickery

Title: Dan Vickery: Innovator in Local Anesthetic Solutions

Introduction

Dan Vickery is a notable inventor based in North Brunswick, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative solutions for local anesthetics. With a total of 2 patents, Vickery's work focuses on improving the stability and efficacy of medical compositions.

Latest Patents

One of Vickery's latest patents is an article of manufacture comprising a local anesthetic, buffer, and glycosaminoglycan in a syringe with improved stability. This invention includes a composition that features a glycosaminoglycan, a local anesthetic, and a buffer, all packaged in a syringe or vial made from either glass or a specific type of plastic. The selected plastics include cyclic olefin polymer, cyclic olefin copolymer, or high-density non-nucleated polypropylene. This innovative composition has shown unexpectedly improved stability during storage. It can be formulated for the treatment of urinary tract diseases or conditions, such as interstitial cystitis, also known as bladder pain syndrome or hypersensitive bladder syndrome.

Career Highlights

Throughout his career, Dan Vickery has worked with several prominent companies in the pharmaceutical industry. Notable among these are Urigen Pharmaceuticals, Inc. and Vaneltix Pharma, Inc. His experience in these organizations has contributed to his expertise in developing effective medical solutions.

Collaborations

Vickery has collaborated with several professionals in his field, including Lowell C. Parsons and Christopher Meenan. These collaborations have likely enhanced his innovative capabilities and contributed to his successful patent applications.

Conclusion

Dan Vickery is a distinguished inventor whose work in local anesthetic solutions has made a significant impact in the medical field. His innovative patents and collaborations reflect his commitment to improving patient care through advanced pharmaceutical formulations.